Sanofi Consumer Healthcare is pushing back on a recommendation that it discontinue the “#1 doctor-recommended” claim for its Zantac 360° heartburn medicine in a case brought by competitor Johnson & ...
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
PARIS, Jan 4 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Wednesday its dispute with Germany's Boehringer Ingelheim over potential liability for cancer claims in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback